Siris Medical empowers clinicians to achieve efficient high-quality cancer treatment decisions. It has commercialized the first FDA 510(k) cleared artificial intelligence decision support platform in radiation oncology. It is a member of both the North Shore InnoVentures and the UCSF / QB3 Rosenman incubation programs.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 09/20/17 | $4,000,000 | Series A-1 |
DigiTx Partners Medical Technology Venture Partners | undisclosed |
